Insulin resistance, which is a major hallmark of NAFLD, impairs hepatic glycogen synthesis through dysregulation of glucokinase translocation from the nucleus to the cytoplasm, a rate-controlling step in insulin-stimulated hepatic glycogen synthesis [43]. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.